Department of Rheumatology, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany.
Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, 40224, Düsseldorf, Germany.
Rheumatol Int. 2023 Aug;43(8):1453-1458. doi: 10.1007/s00296-023-05335-0. Epub 2023 Jun 1.
The long-term outcome of connective tissue diseases is associated with the time from symptom onset to diagnosis. To understand gaps in care, we determine whether the length of time between symptom onset and first presentation to a rheumatologist has changed in Germany in recent decades. We analyzed data on patients diagnosed with connective tissue diseases (n = 19,662) collected from the German National Database of the Regional Cooperative Rheumatology Centers. We reviewed the onset of relevant symptoms listed at first presentations from 1993 to 2018 and performed a quantitative analysis of the intervals until first presentation to a rheumatologist. We compared time intervals and performed a linear mixed regression model with random effects to identify associated factors. Although the interval between the onset of symptoms and first presentation to a rheumatologist has diminished since 1980 for all connective tissue diseases, there has been no relevant improvement during the past 2 decades. The interval between symptoms and presentation increases with patients age for all connective tissue diseases (e.g., Systemic sclerosis; for each 10-year-increment of patients age: β 0.41, CI 0.38; 0.44). Among those diagnosed with systemic sclerosis, the mean interval was 1.5 years (95% CI 1.1; 1.8) for male patients and 2.6 years (95% CI 2.4; 2.8) for females. Patients presenting with different degrees of disease severity on their first visits and with different educational levels had similar mean intervals between symptoms and first presentation regardless of their final diagnoses. Over the past 2 decades, the time to first consultation with a rheumatologist has not continued to improve in Germany, but has stagnated at the same level. Selected patient subgroups, such as older patients with suspected connective tissue diseases and female patients with suspected systemic sclerosis, are at risk to present late and may in particular benefit from an earlier referral to a rheumatologist.
结缔组织疾病的长期预后与从症状出现到诊断的时间有关。为了了解护理中的差距,我们确定在最近几十年中,德国从症状出现到首次就诊风湿科医生的时间是否发生了变化。我们分析了德国区域合作风湿病中心国家数据库中收集的诊断为结缔组织疾病的患者(n=19662)的数据。我们回顾了 1993 年至 2018 年首次就诊时列出的相关症状的发病情况,并对首次就诊风湿科医生的间隔时间进行了定量分析。我们比较了时间间隔,并使用具有随机效应的线性混合回归模型确定了相关因素。尽管自 1980 年以来,所有结缔组织疾病的症状出现与首次就诊风湿科医生之间的间隔都有所缩短,但在过去的 20 年中并没有明显改善。所有结缔组织疾病的症状出现与就诊之间的间隔随患者年龄的增加而增加(例如,系统性硬化症;对于每增加 10 岁的患者年龄:β0.41,CI 0.38;0.44)。在诊断为系统性硬化症的患者中,男性患者的平均间隔为 1.5 年(95%CI 1.1;1.8),女性患者为 2.6 年(95%CI 2.4;2.8)。首次就诊时疾病严重程度不同和教育程度不同的患者,无论最终诊断如何,其症状与首次就诊之间的平均间隔相似。在过去的 20 年中,德国首次咨询风湿科医生的时间并没有继续改善,而是停滞在同一水平。一些选定的患者亚组,如疑似结缔组织疾病的老年患者和疑似系统性硬化症的女性患者,存在就诊时间较晚的风险,特别是可能受益于更早转诊至风湿科医生。